Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy
<p>Abstract</p> <p>Purpose</p> <p>To assess whether an expanded (five level) risk stratification system can be used to identify the sub-group of intermediate risk patients with prostate cancer who benefit from combining androgen deprivation therapy (ADT) with external b...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/3/1/8 |